NextCure Q2 EPS $(0.64) Misses $(0.59) Estimate
Portfolio Pulse from Benzinga Newsdesk
NextCure reported Q2 losses of $(0.64) per share, missing the analyst consensus estimate of $(0.59) by 8.47 percent. However, this is a 1.54 percent increase over losses of $(0.65) per share from the same period last year.
August 04, 2023 | 2:35 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
NextCure's Q2 earnings missed analyst estimates, which could negatively impact investor sentiment.
NextCure's Q2 earnings missed analyst estimates by 8.47%, which could lead to a decrease in investor confidence and potentially a drop in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100